These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25219866)

  • 1. Intestinal uptake of insulin nanoparticles: facts or myths?
    Lopes MA; Abrahim BA; Seiça R; Veiga F; Rodrigues CR; Ribeiro AJ
    Curr Pharm Biotechnol; 2014; 15(7):629-38. PubMed ID: 25219866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption of insulin nanoparticles: contribution of M cells.
    Lopes MA; Abrahim BA; Cabral LM; Rodrigues CR; Seiça RM; de Baptista Veiga FJ; Ribeiro AJ
    Nanomedicine; 2014 Aug; 10(6):1139-51. PubMed ID: 24632248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral insulin delivery: how far are we?
    Fonte P; Araújo F; Reis S; Sarmento B
    J Diabetes Sci Technol; 2013 Mar; 7(2):520-31. PubMed ID: 23567010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
    Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral insulin delivery: existing barriers and current counter-strategies.
    Gedawy A; Martinez J; Al-Salami H; Dass CR
    J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
    Chen MC; Sonaje K; Chen KJ; Sung HW
    Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The design of oral insulin delivery systems based on smart hydrogels].
    Morishita M; Takayama K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():516-21. PubMed ID: 12387044
    [No Abstract]   [Full Text] [Related]  

  • 10. A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery.
    Macedo A; Filipe P; Thomé NG; Vieira J; Oliveira C; Teodósio C; Ferreira R; Roque L; Fonte P
    Curr Mol Med; 2020; 20(2):134-143. PubMed ID: 31965934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin.
    Presas E; McCartney F; Sultan E; Hunger C; Nellen S; V Alvarez C; Werner U; Bazile D; Brayden DJ; O'Driscoll CM
    J Control Release; 2018 Sep; 286():402-414. PubMed ID: 30075208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels.
    Wu S; Bin W; Tu B; Li X; Wang W; Liao S; Sun C
    J Pharm Sci; 2019 Jun; 108(6):2143-2152. PubMed ID: 30721709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles].
    Liu XL; Zhang WJ; Wei G; Lu WY
    Yao Xue Xue Bao; 2012 Apr; 47(4):512-6. PubMed ID: 22799036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
    Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
    AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.